KraneShares MSCI All China Health Care Index ETF
KURENYSEARCAKraneSharesEquity
As of Oct 15, 2026 close
- Assets (AUM)
- $114.29M
- Expense ratio
- 0.65%
- Dividend yield
- 3.99%
- Holdings
- 45
- 52-week range
- $14.38$19.93
- Volume (live)
- -
- Avg. volume (3M)
- 90.87K
KURE ETF: KraneShares MSCI All China Health Care Index ETF - Price, Holdings & Analysis
KraneShares MSCI All China Health Care Index ETF Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $17.85 - $17.89 |
|---|---|
| 52-Week High | $19.93 |
| 52-Week Low | $14.38 |
| Open | $17.85 |
| Volume (last close) | 165.33K |
| Average Volume (3M) | 90.87K |
| 1 Day Change | +0.90% |
|---|---|
| 1 Month Change | +0.34% |
| 6 Month Change | −0.94% |
| YTD Change | +2.93% |
| 1 Year Change | −9.73% |
| 5 Year Change | −50.30% |
| Annual Dividend | $0.71 |
|---|---|
| Dividend Yield | 3.99% |
| Last Dividend Ex-Date | Dec 22, 2025 |
| Dividend Growth YoY | +289.24% |
| Years Dividend Growth | 3 |
| Assets (AUM) | $114.29M |
|---|---|
| Expense Ratio | 0.65% |
| Total Holdings | 45 |
| Inception Date | Jan 31, 2018 |
| 50-Day MA | $18.65 |
|---|---|
| 200-Day MA | $17.49 |
| RSI | 37.38 |
| Stochastic %K | 5.97 |
| Stochastic %D | 5.21 |
Source: Exchange price data and fund disclosures. Data as of Oct 15, 2026. Data sources and methodology
KURE at a Glance
KraneShares MSCI All China Health Care Index ETF (KURE) is an equity ETF from KraneShares, launched in January 2018. It manages $114.29M in assets and charges a 0.65% expense ratio, about $65 a year per $10,000 invested.
As of its Oct 4, 2026 holdings, it holds 45 positions. The largest are Innovent Biologics Inc (HKG:1801, 9.09%), BeOne Medicines AG (HKG:6160, 8.83%) and WuXi Biologics (Cayman) Inc. (HKG:2269, 8.06%). The top 10 holdings make up 59.7% of the fund. By sector it leans toward Healthcare (99.1%) and Consumer Staples (0.9%). Its largest country exposures are China (83.8%), United States (12.0%) and Hong Kong (4.2%).
It pays distributions yielding 3.99% at the Oct 15, 2026 close, $0.71 per share over the trailing 12 months. As of the Oct 15, 2026 close, the share price is down 9.7% over one year and down 50.3% over five years (price change, excluding distributions).
Frequently Asked Questions About KraneShares MSCI All China Health Care Index ETF
What is the current price of KURE?
The latest KURE price is $17.90 (Oct 15, 2026 close). The 52-week range is $14.38–$19.93. The share price is down 9.7% over the past year (price change, excluding distributions).
What is the expense ratio for KURE?
KURE's annual expense ratio is 0.65%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does KURE pay dividends?
Yes, KURE pays a 3.99% dividend yield (trailing 12 months, at the Oct 15, 2026 close). The most recent ex-dividend date was December 22, 2025. View full dividend history in the Dividends section.
What are the top holdings of KURE?
As of Oct 4, 2026, KURE's largest holdings are Innovent Biologics Inc (9.1%), BeOne Medicines AG (8.8%), WuXi Biologics (Cayman) Inc. (8.1%) (combined weight: 26.0%). The fund holds 45 total positions. View the complete portfolio breakdown in the Holdings section.
How does KURE compare to similar ETFs?
Compare KURE (0.65% expense ratio, $114M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.